RECRUITMENT OF UNRELATED BONE MARROW DONORS
招募无关的骨髓捐赠者
基本信息
- 批准号:3441985
- 负责人:
- 金额:$ 7.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-07-01 至 1986-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although bone marrow transplantation is currently the treatment of choice
for several forms of leukemia and aplastic anemia, this therapy is
unavailable for more than 60% of the patients because compatible family
donors do not exist. Technological advances in histocompatability testing
and improvement in post-transplant care have made it feasible to consider
transplants from non-related donors for some patients. Two such
transplants have been performed at Milwaukee Children's Hospital within the
past year and one was previously undertaken in Seattle. Each was
successful. The extreme polymorphism of the HLA system requires large
numbers of willing donors to be screened prior to finding one who is
potentially compatible. The Blood Center of Southeastern Wisconsin
currently maintains a pool of 10,000 active blood donors who are
HLA-typed. Recruitment of blood donors as bone marrow donors raises many
questions of key importance to a regional blood program. We propose to
determine if it is feasible to recruit non-related bone marrow donors from
our HLA-types population; whether a pool of 10,000 individuals is
sufficient for this task; how the various functions related to recruitment
of non-related bone marrow donors should be divided between blood center,
hospital and transplant team; the positive and negative effects on the
overall blood donor recruitment effort; and the psychological and personal
reactions of bone marrow donors, those who decline to donate and those
found not compatible. We also propose to recruit donors for patients at
the Fred Hutchinson Cancer Center in Seattle and to evaluate the many
problems likely to be encountered in sending donors to a distant city. The
latter objective is of considerable significance if this therapy becomes
more generally available, since donors and recipients will not always
reside in close geographic proximity. If successful, it should be possible
for our program to be used as a model for recruitment of donors by other
blood centers interested in developing this capability.
虽然骨髓移植是目前的首选治疗方法
对于多种形式的白血病和再生障碍性贫血,这种疗法是
超过60%的患者因家庭和谐而无法就诊
捐助者不存在。 组织相容性测试的技术进步
以及移植后护理的改善使得考虑
一些患者接受非亲属捐献者的移植。 两个这样的
移植手术已在密尔沃基儿童医院进行
去年,其中一次是在西雅图进行的。 每个都是
成功的。 HLA系统的极端多态性需要大量
在找到合适的捐赠者之前需要对愿意捐赠者的数量进行筛选
潜在兼容。 威斯康星州东南部血液中心
目前拥有 10,000 名活跃的献血者
HLA 型。 招募献血者作为骨髓捐献者筹集了许多
对区域血液计划至关重要的问题。 我们建议
确定是否可以从以下来源招募非亲属骨髓捐献者
我们的 HLA 型人群;是否有 10,000 人的池
足以完成这项任务;各个职能如何与招聘相关
非血缘关系的骨髓捐献者应在血液中心、
医院和移植团队;的积极和消极影响
总体献血者招募工作;以及心理和个人
骨髓捐献者、拒绝捐献者和骨髓捐献者的反应
发现不兼容。 我们还建议为患者招募捐赠者
西雅图 Fred Hutchinson 癌症中心并评估了许多
将捐赠者送往遥远城市时可能会遇到的问题。 这
如果这种疗法成为,后一个目标将具有相当大的意义
更普遍,因为捐助者和接受者并不总是
居住在地理上接近的地方。 如果成功的话应该是可以的
让我们的计划成为其他组织招募捐助者的典范
血液中心对发展这种能力感兴趣。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recruitment of unrelated persons as bone marrow donors. A preliminary experience.
招募无关人员作为骨髓捐献者。
- DOI:
- 发表时间:1986-07
- 期刊:
- 影响因子:2.9
- 作者:McElligott, M C;Menitove, J E;Aster, R H
- 通讯作者:Aster, R H
Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
成功地将来自 HLA 密切匹配的无关供体的 T 细胞耗尽的骨髓进行同种异体移植。
- DOI:
- 发表时间:1990-02-22
- 期刊:
- 影响因子:0
- 作者:Ash, R C;Casper, J T;Chitambar, C R;Hansen, R;Bunin, N;Truitt, R L;Lawton, C;Murray, K;Hunter, J;Baxter
- 通讯作者:Baxter
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jay E Menitove其他文献
Jay E Menitove的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jay E Menitove', 18)}}的其他基金
TRANSFUSION TRIAL TO PREVENT PLATELET ALLOIMMUNIZATION
预防血小板同种免疫的输血试验
- 批准号:
3553376 - 财政年份:1989
- 资助金额:
$ 7.3万 - 项目类别:
TRANSFUSION TRIAL TO PREVENT PLATELET ALLOIMMUNIZATION
预防血小板同种免疫的输血试验
- 批准号:
3553375 - 财政年份:1989
- 资助金额:
$ 7.3万 - 项目类别:
相似国自然基金
献血/浆人群中人细小病毒B19的亲缘地理学与群体遗传学研究
- 批准号:81300395
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
急性输血性肺损伤HLA和HNA抗体特异性研究
- 批准号:81102294
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance
一种新颖且临床可行的联合疗法,将已故供体骨髓与供体匹配的间充质干细胞相结合,以建立免疫耐受
- 批准号:
10212956 - 财政年份:2020
- 资助金额:
$ 7.3万 - 项目类别:
A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance
一种新颖且临床可行的联合疗法,将已故供体骨髓与供体匹配的间充质干细胞相结合,以建立免疫耐受
- 批准号:
10081139 - 财政年份:2020
- 资助金额:
$ 7.3万 - 项目类别: